« previous next »
Pages: [1]

Author Topic: (Abst.) ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for MS  (Read 57 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9670
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for MS
« on: February 23, 2020, 03:20:27 pm »
From PubMed (February 23, 2020), "ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis"


https://www.ncbi.nlm.nih.gov/pubmed/32081100


ANCA vasculitis:


Quote
ANCA vasculitis is an autoimmune disease affecting small blood vessels in the body. It is caused by autoantibodies called ANCAs, or [/size]A[/color][/size]nti-[/color][/size]N[/color][/size]eutrophilic [/color][/size]C[/color][/size]ytoplasmic [/color][/size]A[/color][/size]utoantibodies. ANCAs target and attack a certain kind of white blood cells called neutrophils. They target a part of neutrophils called the cytoplasm (the inside of the cell.)[/color]


[from the UNC Kidney Center Website]
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics